Literature DB >> 11085876

Multiple subcellular localizations of PCTAIRE-1 in brain.

F Le Bouffant1, P Le Minter, E Traiffort, M Ruat, F Sladeczek.   

Abstract

We developed a selective antibody to a synthetic peptide corresponding to an N-terminal sequence of the PCTAIRE-1 protein. In rodent brain extracts it recognized only the protein doublet characteristic of PCTAIRE-1, and this signal is completely abolished by preincubation of the antibody with the immunopeptide. Immunolabeling experiments done with this PCTAIRE-1-specific antibody reveal that the protein is widely distributed in the rodent brain as are the mRNAs visualized using an antisense riboprobe corresponding to the entire PCTAIRE-1 open reading frame. Two types of PCTAIRE-1 protein localizations were observed: first a diffuse labeling of almost all brain regions, particularly intense in the molecular layer of the cerebellum and the mossy fiber region of the hippocampus, and second a spot-like localization in the nuclei of large neurons such as cerebellar Purkinje cells and pyramidal cells of the hippocampus. Colocalization with the B23 protein allows one to identify these compartments as nucleoli. Our results suggest a nucleolar function of PCTAIRE-1 in large neurons and a role in regions containing important granule cell projections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085876     DOI: 10.1006/mcne.2000.0881

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  9 in total

1.  Involvement of cyclin-dependent kinase-like 2 in cognitive function required for contextual and spatial learning in mice.

Authors:  Hiroshi Gomi; Takayuki Sassa; Richard F Thompson; Shigeyoshi Itohara
Journal:  Front Behav Neurosci       Date:  2010-04-19       Impact factor: 3.558

2.  PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells.

Authors:  Teruki Yanagi; Maryla Krajewska; Shu-ichi Matsuzawa; John C Reed
Journal:  Cancer Res       Date:  2014-09-09       Impact factor: 12.701

3.  Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis.

Authors:  Petra Mikolcevic; Reinhard Sigl; Veronika Rauch; Michael W Hess; Kristian Pfaller; Marin Barisic; Lauri J Pelliniemi; Michael Boesl; Stephan Geley
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

4.  PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.

Authors:  Teruki Yanagi; Ranxin Shi; Pedro Aza-Blanc; John C Reed; Shu-ichi Matsuzawa
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma.

Authors:  Teruki Yanagi; John C Reed; Shu-Ichi Matsuzawa
Journal:  Oncoscience       Date:  2014-10-05

6.  Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.

Authors:  Yitao Wang; Xian Qin; Tao Guo; Pengpeng Liu; Ping Wu; Zhisu Liu
Journal:  J Exp Clin Cancer Res       Date:  2017-07-17

7.  Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex.

Authors:  Sara Hernández-Ortega; Abril Sánchez-Botet; Eva Quandt; Núria Masip; Laura Gasa; Gaetano Verde; Javier Jiménez; Rebecca S Levin; Florentine U Rutaganira; Alma L Burlingame; Don Wolfgeher; Mariana P C Ribeiro; Stephen J Kron; Kevan M Shokat; Josep Clotet
Journal:  Exp Mol Med       Date:  2019-04-16       Impact factor: 8.718

Review 8.  Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.

Authors:  Petra Mikolcevic; Johannes Rainer; Stephan Geley
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

9.  Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth.

Authors:  Teruki Yanagi; Kiyoshi Tachikawa; Rachel Wilkie-Grantham; Asami Hishiki; Ko Nagai; Ellen Toyonaga; Pad Chivukula; Shu-Ichi Matsuzawa
Journal:  Mol Ther Nucleic Acids       Date:  2016-06-28       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.